NCT01830452

Brief Summary

Chronic pain after Lichtenstein hernioplasty is a common problem with an incidence of 11%. Many factors influence the onset and persistence of pain. Mesh characteristics and fixation have been pointed as important etiologic factors. This study compares two types of fixation for the same mesh. The mesh used is a lightweight parietex mesh. In the control group this mesh will be fixed with non absorbable sutures. In the study group sutures will not be needed because of self gripping microhooks on the surface of the mesh. Methods: The HIPPO trial is a multicenter double blind randomized clinical trial. Patients will be randomly allocated to the sutured mesh or the self-gripping mesh. Hernia repair will be done according to Lichtenstein as described by Amid et all. Included will be all unilateral primary inguinal hernia in man patients aged 18 years or older not meeting the exclusion criteria. Patients will be followed for two years. The main endpoint is the amount of post-operative chronic pain evaluated by VAS scores. The existence of neuropathic pain will be evaluated by the Paindetect questionnaire (and a bedside variant of the QST). Secondary endpoints are recurrence rate, post-operative complications, costs, hospital stay, QOL, return to work and daily activities, genital and sexual problems. To demonstrate a difference in VAS score of 10 with α=0.05 and power 80% a sample size of 400 patients is calculated. Discussion: Hypothesized is that the self gripping non-sutured mesh (Parietex Progrip) will cause less post-operative and chronic pain without enhancing the recurrence rate.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Sep 2010

Longer than P75 for phase_4

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2010

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

February 6, 2013

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 12, 2013

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
Last Updated

April 12, 2013

Status Verified

April 1, 2013

Enrollment Period

4.5 years

First QC Date

February 6, 2013

Last Update Submit

April 9, 2013

Conditions

Keywords

Chronic painProgrip MeshSelf gripping meshLichtenstein

Outcome Measures

Primary Outcomes (1)

  • Incidence of chronic post-operative inguinal pain

    The definition of chronic pain given by the IASP will be used.

    12 months

Secondary Outcomes (1)

  • Recurrence rate

    12 months

Other Outcomes (4)

  • per- and post operative complications

    3 months

  • Operating time

    Day of surgery

  • Quality of life

    12 months

  • +1 more other outcomes

Study Arms (2)

Parietex Progrip mesh

EXPERIMENTAL

Ventral hernioplasty using a (self gripping / self adhering / self fixating) Progrip mesh not needing fixation devices

Procedure: Self-fixating Parietex Progrip Mesh

Parietex Mesh

ACTIVE COMPARATOR

Ventral hernioplasty using a polyester mesh fixed with non absorbable sutures as described by Lichtenstein/Amid

Procedure: Self-fixating Parietex Progrip Mesh

Interventions

Lichtenstein hernioplasty using a self fixating Parietex Progrip mesh not needing any fixating devices

Also known as: Open hernioplasty, Inguinal hernioplasty, Anterior hernioplasty
Parietex MeshParietex Progrip mesh

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Primary unilateral inguinal hernia
  • Capacitated male person
  • Age ≥ 18 years

You may not qualify if:

  • Concurrent femoral hernia
  • Incarcerated or strangulated inguinal hernia
  • ASA 4 or ASA 5
  • Impaired adequate follow up
  • Participation in another trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Groene Hart Ziekenhuis

Gouda, 2800BB, Netherlands

RECRUITING

Sint Franciscus Gasthuis

Rotterdam, 3045 PM, Netherlands

RECRUITING

Related Publications (1)

  • Molegraaf MJ, Grotenhuis B, Torensma B, de Ridder V, Lange JF, Swank DJ. The HIPPO Trial, a Randomized Double-blind Trial Comparing Self-gripping Parietex Progrip Mesh and Sutured Parietex Mesh in Lichtenstein Hernioplasty: A Long-term Follow-up Study. Ann Surg. 2017 Dec;266(6):939-945. doi: 10.1097/SLA.0000000000002169.

MeSH Terms

Conditions

Hernia, InguinalChronic Pain

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Johan F Lange, Prof

    Erasmus Medical Center

    STUDY DIRECTOR

Central Study Contacts

Marijke J Molegraaf, MD

CONTACT

Marijn Takkenberg, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

February 6, 2013

First Posted

April 12, 2013

Study Start

September 1, 2010

Primary Completion

March 1, 2015

Study Completion

March 1, 2015

Last Updated

April 12, 2013

Record last verified: 2013-04

Locations